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Methods of in vitro mutagenesis were employed to determine the importance of individual nucleotides with- 
in the ribosomal RNAs for the structure and function of E. coli ribosomes. A series of defined nucleotides 
in the genes for the 5 S and 16 S RNA were altered by transition and transversion mutations using either 
oligonucleotide-directed or bisulfite-catalyzed mutation procedures. Plasmids harbouring the mutated 
rRNA genes were expressed and the ribosomes containing such altered RNAs were investigated for impair- 
ments in RNA-protein interaction assembly and mRNA-coded tRNA binding. 
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1. INTRODUCTION 
A number of recent reports have convincingly 
demonstrated that some RNAs have enzyme-like 
functional activities [ 1,3]. Similar observations are 
true for ribosomal RNAs, pointing to a functional 
importance of defined sequence regions for in- 
dividual steps in the mechanism of translation 
13-61. 
Using methods of chemical modification, cross- 
linking and limited enzymatic hydrolysis, we and 
others have provided a catalogue of individual 
nucleotides within the ribosomal RNAs that may 
be of potential importance for a number of 
ribosomal functions [5-l I]. Whether these 
nucleotides are actually important and how they 
mediate possible functions can be determined by 
base substitutions of the corresponding sites and 
assessment of the structural and functional im- 
pairments of the resulting molecules. 
* TO whom correspondence should be addressed 
Here we report on the analysis of effects caused 
by single- and multiple-site mutations within the 
gene for the ribosomal 5 S RNA, and on the con- 
struction and functional analysis of point mutants 
at the 3’-end of the 16 S RNA. The mutated 5 S 
RNAs were analyzed for their capacity to form 
stable complexes with the binding proteins LS, L18 
and L25. Furthermore, the effects on the tRNA 
binding capacity of ribosomes containing such 
mutated 5 S RNAs were investigated. The same 
assay was employed for ribosomal mutants with 
base changes at the 3’-end of the 16 S RNA. These 
mutants were additionally tested with respect to 
their subunit association equilibrium. It turned out 
that a single-site mutation in the 16 S RNA 
decreased the stability of 70 S ribosomes 
dramatically. 
2. MATERIALS AND METHODS 
The following strains were used for the construc- 
tion and expression of the rRNA mutants: HBlOl 
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[12], JM103/JM105 [13], CSR603 [14] and 
WM1151, a derivative of W3110 [15]. The 
ribosomal RNAs containing plasmid vectors 
pKK3535 [16] and pKK223-3 [17] were used for 
cloning and expression of mutant genes. The ex- 
pression vector pLSK34- 1, a pK-01 derivative [ 181, 
was kindly provided by R. Kiilling and used for ex- 
pression of mutant 5 S RNA genes. The Ml3 
phage DNA mp8, mpl0 were purchased from P.L. 
Biochemicals. Methods for recombination of DNA 
were applied as described by Maniatis et al. [ 191. 
DNA sequencing was performed according to 
Sanger et al. [20]. For the selective expression of 
plasmid-coded rRNAs in maxicells the method 
developed by Stark et al. [21] was followed. 
Oligonucleotide-directed point mutants in the 5 S 
RNA gene were constructed as described [22,23]. 
The bisulfite-catalyzed transition mutants were 
constructed according to [24]. Details of the muta- 
tion procedures of the 5 S RNA and 16 S RNA 
mutants are described elsewhere [25,26]. 
3. RESULTS AND DISCUSSION 
The following ribosomal RNA mutants have 
been obtained: (i) Point mutations constructed by 
oligonucleotide-directed mutagenesis at the 5 S 
RNA positions: 41 (G to C); 66 (A to C) and 103 
(U to G). (ii) Bisulfite-catalyzed transition mutants 
within the 5 S RNA. A collection of G to A transi- 
tions that have been sequenced is shown in table 1. 
(iii) Oligonucleotide-directed point mutants at the 
3 ‘-end of the 16 S RNA: Cl399 to A/G1401 to C; 
Cl399 to A/G1401 to U and G1416 to U. 
The different mutants were screened by dot-blot 
analysis [27] and in the case of the bisulfite- 
catalyzed transition mutants by two-lane sequenc- 
ing. In all cases the base changes were verified by 
direct DNA sequencing [ZO]. An example for one 
of the 16 S RNA mutants is shown in fig.1. Most 
of the 5 S RNA mutants were additionally 
characterized by RNA sequencing of the mutant 
genes, after expression in maxicells. 
Table 1 
Collection of bisulfite-catalyzed G to A transition mutants 
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Fig. 1. DNA sequencing el demonstrating the Urar6 base 
change mutation in the 16 S RNA gene. The sequences 
of DNA fragments comprising the 3’-end of the 16 S 
RNA are shown from wild-type and LJr~t,j mutant 
molecules. The base change at position 1416 is indicated 
by an arrow. XC denotes the xylene cyan01 marker dye. 
3.1. Expression of mutant RNAs 
The 5 S RNA genes with point mutations at 
positions 41, 66 and 103, as well as the 16 S RNA 
point mutants, were recloned in the plasmid vector 
pKK3535 [16] where the complete rrnB operon is 
expressed under the control of the normal 
ribosomal RNA promoters. The 5 S RNA mutant 
genes constructed by bisulfite-catalyzed transitions 
were cloned in the expression vector pLSK34-1 
where transcription could be induced by the addi- 
tion of IPTG to the growing cells. Both expression 
systems were similar in efficiency but had the 
disadvantage that wild-type ribosomal RNA, 
transcribed from the 7 chromosomal operons, con- 
taminated the mutant RNAs. We estimate the con- 
tribution of mutated RNA to wild-type RNA to be 
about 50% with slight variations for the different 
mutants ([22], unpublished). 
For a selective expression of the mutated RNAs 
we used the maxicell labeling procedure developed 
by Stark et al. [21]. Using this approach pure 
radioactive mutant RNAs could be obtained and 
also ribosomes containing mutated rRNAs could 
be distinguished from those assembled from wild- 
type RNA. Fig.2 shows an example of the selective 
ribosomal RNA transcription from plasmids using 
the maxicell procedure. 
3.2. Protein binding studies employing mutated 
5 S RNAs 
The mutant 5 S RNA molecules isolated after 
maxicell labeling or, in the case of the bisulfite 
mutants, after induction of cell cultures with 
IPTG, were purified and renatured to obtain the 
active protein binding conformer [5]. The 5 S 
RNA mutants induced by IPTG can be separated 
from the chromosomal transcribed wild-type 5 S 
RNAs due to a difference in processing. The defec- 
tive processing provides 5 S RNA molecules, two 
bases longer than normal 5 S RNA. The protein 
binding of the longer molecules is, however, not 
affected [28]. The ribosomal proteins L5, L18 and 
L25, kindly provided by Dr J. Dijk, were used for 
complex formation with the mutated RNAs. The 
5 S RNA-protein complexes were quantified by the 
filter binding procedure [29] and binding constants 
were determined as described in [23,30]. Table 2 
shows a collection of some of the apparent binding 
constants for the proteins L18 and L25 where helix 
II, the putative interacting domain for L18, has 
been altered by an increasing number of muta- 
tions. The theoretical stability of helix II from the 
various mutants, calculated according to the Zuker 
algorithm [3 I], is shown for comparison in table 2. 
Interestingly, the binding constants for L18 are not 
as strongly affected as one would expect according 
to the hypothesis that helix II, and especially the 
bulged out nucleotide A66, constitutes the main 
binding site for the ribosomal protein L18 [ll]. In 
contrast, and as table 2 clearly shows, the binding 
of the ribosomal protein L25 seems to be more 
stringently related to an intact helical geometry of 
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Fig.2. RNA analysis after maxicell labeling. Total RNA preparations from CSR 603 cells containing the different 
plasmids pKK3535, pBR322 and pC41, a pKK 3535 derivative with a point mutation at position 41 of the 5 S RNA 
gene, were separated after UV irradiation. The irradiation time in minutes and the positions of the ribosomal RNAs 
are indicated. Note that pBR322 does not code for ribosomal RNAs. 
Table 2 
Comparison of helix II stability and binding constants 
-_(_(;_G-C-&G-“-G-- 
WILD TYPE I I I I I I 
-_C_(;*“_G_C_C_C_C__ 
-_G_(_G-C-G-G-Ll-G-- 
C-66 --h-h c &;_&;__ 
Q 
--G-C-G_C _ G-G-U_G-- 
15.04 , --::-~,&~-c-C-- 
42 3.1 x lo5 2.9 x 106 
6 
-61.7 3.8 x 105 5.3 x 10 
23.9 3.3 x 105 2.7 x lo6 
60.30 
__y_y_(;,c@G-U-G-- 
I - 9.7 2.7 x IO5 2.5 x lo6 
__@A-“-G-C/C-C-C-- 
140.34 
__;z+;y;ig- 
11.8 2.1 x 105 8.3 x lo5 
C C-- 
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helix II. The decline in complex stability between 
L25 and the different 5 S RNA mutants seems to 
be much more dependent on the stability of helix 
II as for LIS. Note that an increase in the 
theoretical stability of helix II also leads to an in- 
crease in the binding constant between the 5 S 
RNA mutant and L25. These data strongly imply 
that our current view of the association sites be- 
tween 5 S RNA and the ribosomal proteins L18 
and L25 must be reconsidered and that some of the 
interpretations from limited enz~atic digestion 
and chemical modification studies have to be 
modified (see also [23]). 
3.3. Effects of 5 S RNA point mutations on tRNA 
binding 
Ribosomes containing mutated 5 S RNAs, with 
base changes at positions 41 (G to C), 66 (A to C) 
or 103 (U to G) were tested in their poly(U)- 
dependent Phe-tRNA binding capacity. The 
binding assay was performed as described [23] 
using 32P-labeled 70 S ribosomes isolated from 
maxicells. Table 3 shows the relative tRNA and 
poly(U) binding activities of the mutants compared 
to wild-type ribosomes. The following conclusions 
can be drawn from the results presented in table 3: 
(i) All three mutants with base changes at either 
one of the positions 41, 66 or 103 show significant- 
ly reduced tRNA binding activities in our in vitro 
assay. (ii) While the mutants with base changes at 
positions 41 and 66 have a strongly reduced affini- 
ty for poly(U) the poly(U) affinity of the mutant at 
position 103 is in the same range as for the wild- 
type ribosomes. 
The results have also been confirmed using non- 
radioactive ribosome preparations isolated from 
Table 3 
Affinity of ribosomes for poly(U) and Phe-tRNA 
SSRNA Poly(U) Poly(U) + Difference 
mutant Phe-tRNA 
Wild-type 11.9 17.9 6.0 
pc 41 4.6 5.9 1.3 
PC 66 7.2 7.0 - 
pG 103 14.2 14.0 
The numbers indicate the percentage of ribosomes 
retained on the affinity supports (see section 2). Values 
are averaged from 3 ~nde~ndent experiments 
normal cells where a mixture of mutant and wild- 
type ribosomes is assayed. Since the cells contain- 
ing plasmids with the mutated 5 S RNA genes do 
not show significant differences in their growth 
rates in YT medium we do not known how the 
deficiency in tRNA or mRNA binding of the mu- 
tant ribosomes is compensated in the cell. This is 
somewhat surprising because, according to our 
estimation, about 50% of the ribosomes contain 
mutated 5 S RNA. 
3.4. Effects of base change mutalions at the 
3 ‘-end of the 16 S RNA 
The 3 ‘-end of the 16 S RNA has been proven in 
a number of studies to be of special functional im- 
portance for the translating ribosome. It plays an 
active role in initiation of translation (review [32]). 
A cross-link between base Cl400 and a base of P- 
site-bound tRNA demonstrates the close spatial 
neighbourhood to the P-site [lo]. A number of 
defined nucleotides within the 3 ‘-end of the 16 S 
RNA show strong accessibility changes towards 
chemical modification in different functional 
states of the ribosome. The sequence position G1401 
for instance is strongly protected from DMS 
methylation in ribosomes with bound tRNA as op- 
posed to free ribosomes. Another example is G14,6 
which can be methylated by DMS in 70 S 
Fig.3. Sucrose gradient separation of ribosomes from 
cells containing different plasmids. Sedimentations were 
performed at 6 mM MgZf. Ribosomes were prepared 
after maxiceli labeling and the radioactivity of the 
different fractions was monitored. (A) Wild-type 
ribosomes; in (B-D) the various base change mutations 
within the 16 S RNA gene are indicated. 
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ribosomes but seems to be unreactive in 30 S 
subunits [6,7]. Base change mutations were 
therefore constructed at these two sequence posi- 
tions. The two double mutants C1399 to A, G1401 to 
C and Cl399 to A, Gi401 to U as well as the point 
mutant Gi416 to U were tested for their functional 
influence on ribosomes containing these mutated 
RNAs. The growth rates in rich medium of all 
three mutants were not significantly altered when 
compared to cells containing the wild-type 
plasmid. All three mutant RNAs were processed 
correctly and incorporated into ribosomes. ‘*P 
labeled ribosomes isolated from maxicells were 
consequently tested for their tRNA binding activi- 
ty and subunit association behavior. Both maxicell 
ribosomes and the mixture of mutant and wild- 
type ribosomes isolated from normal cells were 
unaltered in their in vitro tRNA binding. (The 
same poly(U)-dependent Phe-tRNA binding assay 
as described for the 5 S RNA mutants was 
employed.) 
When the three mutants were tested for im- 
pairments in subunit association by sedimentation 
in sucrose gradients in the presence of 6 mM Mg*+ 
the G1416 to U mutant gave a completely abnormal 
sedimentation. profile (see fig.3). While the other 
mutants gave a 70 S peak comparable with the one 
obtained with wild-type ribosomes the u1416 mu- 
tant RNA containing ribosomes sedimented 
predominantly as 30 S subunits. One has to con- 
clude that ribosomes with the u1416 mutation in 
their 16 S RNA do not form stable 70 S ribosomes 
under the sucrose gradient conditions. Com- 
parison of the 16 S RNA from the small 70 S peak 
and the large 30 S peak from the gradient profiles 
of the u1416 mutant confirmed this notion. 
Whereas the 30 S peak consisted mainly of mutant 
u1416 ribosomal 16 S RNA the remaining 70 S 
peak was composed of wild-type 30 S ribosomes. 
To investigate further whether the loss of 70 S 
stability was a direct effect of the altered 16 S 
RNA sequence or mediated by a disturbed protein 
interaction of the mutant ribosomes, we compared 
the protein composition of wild-type and mutant 
II1416 30 S particles. Initial observations with mu- 
tant ribosomes containing an additional protein 
could not be confirmed, and a thorough investiga- 
tion of the protein composition of the mutant and 
wild-type 30 S did not reveal a different protein 
pattern. The effect we observe must therefore be 
94 
directly related to a structural alteration of 30 S 
particles containing the G to U base change at posi- 
tion 1416. 
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